Literature DB >> 12941915

Distinct cycling CD4(+)- and CD8(+)-T-cell profiles during the asymptomatic phase of simian immunodeficiency virus SIVmac251 infection in rhesus macaques.

V Monceaux1, R Ho Tsong Fang, M C Cumont, B Hurtrel, J Estaquier.   

Abstract

Elevated CD4 T-cell turnover may lead to the exhaustion of the immune system during human immunodeficiency virus type 1 (HIV-1) and simian immunodeficiency virus (SIV) infections. However, this hypothesis remains controversial. Most studies of this subject have concerned the blood, and information about the lymph nodes is rare and controversial. We used Ki67 expression to measure cycling T cells in the blood and lymph nodes of uninfected macaques and of macaques infected with a pathogenic SIVmac251 strain or with a nonpathogenic SIVmac251Deltanef clone. During the asymptomatic phase of infection, the number of cycling CD8(+) T cells progressively increased (two- to eightfold) both in the blood and in the lymph nodes of macaques infected with SIVmac251. This increase was correlated with viral replication and the progression to AIDS. In contrast, no increases in the numbers of cycling CD4(+) T cells were found in the blood or lymph nodes of macaques infected with the pathogenic SIVmac251 strain in comparison with SIVmac251Deltanef-infected or healthy macaques during this chronic phase. However, the lymph nodes of pre-AIDS stage SIVmac251-infected macaques contained more cycling CD4(+) T cells (low baseline CD4(+)-T-cell counts in the blood). Taken together, these results show that the profiles of CD4(+)- and CD8(+)-T-cell dynamics are distinct both in the lymph nodes and blood and suggest that higher CD4(+)-T-cell proliferation at the onset of AIDS may lead to the exhaustion of the immune system.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12941915      PMCID: PMC224564          DOI: 10.1128/jvi.77.18.10047-10059.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  73 in total

1.  CD27 is required for generation and long-term maintenance of T cell immunity.

Authors:  J Hendriks; L A Gravestein; K Tesselaar; R A van Lier; T N Schumacher; J Borst
Journal:  Nat Immunol       Date:  2000-11       Impact factor: 25.606

2.  Impact of HIV-1 infection and highly active antiretroviral therapy on the kinetics of CD4+ and CD8+ T cell turnover in HIV-infected patients.

Authors:  R A Lempicki; J A Kovacs; M W Baseler; J W Adelsberger; R L Dewar; V Natarajan; M C Bosche; J A Metcalf; R A Stevens; L A Lambert; W G Alvord; M A Polis; R T Davey; D S Dimitrov; H C Lane
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

3.  Type 1/type 2 cytokine modulation of T-cell programmed cell death as a model for human immunodeficiency virus pathogenesis.

Authors:  M Clerici; A Sarin; R L Coffman; T A Wynn; S P Blatt; C W Hendrix; S F Wolf; G M Shearer; P A Henkart
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

4.  Activation, survival and apoptosis of CD45RO+ and CD45RO- T cells of human immunodeficiency virus-infected individuals: effects of interleukin-15 and comparison with interleukin-2.

Authors:  H Naora; M Gougeon
Journal:  Immunology       Date:  1999-06       Impact factor: 7.397

Review 5.  Mechanisms of HIV-associated lymphocyte apoptosis.

Authors:  A D Badley; A A Pilon; A Landay; D H Lynch
Journal:  Blood       Date:  2000-11-01       Impact factor: 22.113

Review 6.  T cell depletion in HIV-1 infection: how CD4+ T cells go out of stock.

Authors:  M D Hazenberg; D Hamann; H Schuitemaker; F Miedema
Journal:  Nat Immunol       Date:  2000-10       Impact factor: 25.606

7.  Effect of recent thymic emigrants on progression of HIV-1 disease.

Authors:  A Hatzakis; G Touloumi; R Karanicolas; A Karafoulidou; T Mandalaki; C Anastassopoulou; L Zhang; J J Goedert; D D Ho; L G Kostrikis
Journal:  Lancet       Date:  2000-02-19       Impact factor: 79.321

8.  Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood.

Authors:  H Jonuleit; E Schmitt; M Stassen; A Tuettenberg; J Knop; A H Enk
Journal:  J Exp Med       Date:  2001-06-04       Impact factor: 14.307

9.  Naive T cells transiently acquire a memory-like phenotype during homeostasis-driven proliferation.

Authors:  A W Goldrath; L Y Bogatzki; M J Bevan
Journal:  J Exp Med       Date:  2000-08-21       Impact factor: 14.307

10.  Homeostasis-stimulated proliferation drives naive T cells to differentiate directly into memory T cells.

Authors:  B K Cho; V P Rao; Q Ge; H N Eisen; J Chen
Journal:  J Exp Med       Date:  2000-08-21       Impact factor: 14.307

View more
  21 in total

1.  Virus-specific T cell responses in macaques acutely infected with SHIV(sf162p3).

Authors:  Bapi Pahar; Xiaolei Wang; Jason Dufour; Andrew A Lackner; Ronald S Veazey
Journal:  Virology       Date:  2007-02-16       Impact factor: 3.616

2.  Nonpathogenesis of simian immunodeficiency virus infection is associated with reduced inflammation and recruitment of plasmacytoid dendritic cells to lymph nodes, not to lack of an interferon type I response, during the acute phase.

Authors:  Laure Campillo-Gimenez; Mireille Laforge; Michèle Fay; Audrey Brussel; Marie-Christine Cumont; Valérie Monceaux; Ousmane Diop; Yves Lévy; Bruno Hurtrel; John Zaunders; Jacques Corbeil; Carole Elbim; Jérôme Estaquier
Journal:  J Virol       Date:  2009-11-25       Impact factor: 5.103

Review 3.  Generalized immune activation and innate immune responses in simian immunodeficiency virus infection.

Authors:  Steven E Bosinger; Donald L Sodora; Guido Silvestri
Journal:  Curr Opin HIV AIDS       Date:  2011-09       Impact factor: 4.283

4.  Role of thymic output in regulating CD8 T-cell homeostasis during acute and chronic viral infection.

Authors:  Nicole E Miller; Jennifer R Bonczyk; Yumi Nakayama; M Suresh
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

5.  The anti-caspase inhibitor Q-VD-OPH prevents AIDS disease progression in SIV-infected rhesus macaques.

Authors:  Mireille Laforge; Ricardo Silvestre; Vasco Rodrigues; Julie Garibal; Laure Campillo-Gimenez; Shahul Mouhamad; Valérie Monceaux; Marie-Christine Cumont; Henintsoa Rabezanahary; Alain Pruvost; Anabela Cordeiro-da-Silva; Bruno Hurtrel; Guido Silvestri; Anna Senik; Jérôme Estaquier
Journal:  J Clin Invest       Date:  2018-03-19       Impact factor: 14.808

6.  Efficient mucosal transmissibility but limited pathogenicity of R5 SHIV SF162P3N in Chinese-origin rhesus macaques.

Authors:  Alexandra Mumbauer; Agegenhu Gettie; James Blanchard; Cecilia Cheng-Mayer
Journal:  J Acquir Immune Defic Syndr       Date:  2013-04-15       Impact factor: 3.731

7.  Early divergence in neutrophil apoptosis between pathogenic and nonpathogenic simian immunodeficiency virus infections of nonhuman primates.

Authors:  Carole Elbim; Valerie Monceaux; Yvonne M Mueller; Mark G Lewis; Stephanie François; Ousmane Diop; Khadija Akarid; Bruno Hurtrel; Marie-Anne Gougerot-Pocidalo; Yves Lévy; Peter D Katsikis; Jerome Estaquier
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

8.  Treatment with anti-FasL antibody preserves memory lymphocytes and virus-specific cellular immunity in macaques challenged with simian immunodeficiency virus.

Authors:  Bhawna Poonia; Maria S Salvato; Hideo Yagita; Toshihiro Maeda; Ko Okumura; C David Pauza
Journal:  Blood       Date:  2009-06-04       Impact factor: 22.113

9.  Divergent kinetics of proliferating T cell subsets in simian immunodeficiency virus (SIV) infection: SIV eliminates the "first responder" CD4+ T cells in primary infection.

Authors:  Xiaolei Wang; Huanbin Xu; Bapi Pahar; Andrew A Lackner; Ronald S Veazey
Journal:  J Virol       Date:  2013-04-17       Impact factor: 5.103

10.  CD4+ CCR5+ T-cell dynamics during simian immunodeficiency virus infection of Chinese rhesus macaques.

Authors:  V Monceaux; L Viollet; F Petit; M C Cumont; G R Kaufmann; A M Aubertin; B Hurtrel; G Silvestri; J Estaquier
Journal:  J Virol       Date:  2007-09-26       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.